AN2 Therapeutics, Inc. SEC filings ANTX
AN2 Therapeutics, Inc. has 384 filings in SEC EDGAR's recent list, going back to Sep 24, 2021. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 13, 2026 | Oct 12, 2026 |
| 4 | Insider transaction | Oct 13, 2026 | Oct 12, 2026 |
| 4 | Insider transaction | Oct 13, 2026 | Oct 12, 2026 |
| 4 | Insider transaction | Sep 16, 2026 | Sep 15, 2026 |
| S-8 | Employee stock plan registration | Sep 14, 2026 | — |
| 4 | Insider transaction | Sep 11, 2026 | Sep 9, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 3, 2026 |
| 4 | Insider transaction | Sep 4, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Sep 2, 2026 | Sep 1, 2026 |
| 3 | Initial insider ownership | Aug 27, 2026 | Aug 24, 2026 |
| 4 | Insider transaction | Aug 19, 2026 | Aug 17, 2026 |
| 144 | Notice of proposed sale | Aug 17, 2026 | — |
| 4 | Insider transaction | Aug 14, 2026 | Aug 14, 2026 |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 4 | Insider transaction | Jul 10, 2026 | Jul 10, 2026 |
| 4 | Insider transaction | Jul 10, 2026 | Jul 10, 2026 |
| 4 | Insider transaction | Jul 10, 2026 | Jul 10, 2026 |
| 4 | Insider transaction | Jul 10, 2026 | Jul 8, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 4, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | May 29, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 11, 2026 | May 11, 2026 |
| ARS | Annual report to shareholders | Apr 22, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 22, 2026 | — |
| DEF 14A | Proxy statement | Apr 22, 2026 | Apr 22, 2026 |
| EFFECT | Filing | Apr 20, 2026 | — |
| 424B3 | Prospectus | Apr 20, 2026 | — |
| 424B5 | Prospectus supplement | Apr 20, 2026 | — |
| CORRESP | Letter to the SEC | Apr 16, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 15, 2026 | — |
| 4 | Insider transaction | Apr 10, 2026 | Apr 10, 2026 |
| 4 | Insider transaction | Apr 10, 2026 | Apr 10, 2026 |
| 4 | Insider transaction | Apr 10, 2026 | Apr 10, 2026 |
| S-3 | Shelf registration | Apr 9, 2026 | — |
| 8-K |
Current report
Other events
|
Apr 9, 2026 | Apr 9, 2026 |
| D | Filing | Mar 25, 2026 | — |
| 4 | Insider transaction | Mar 23, 2026 | Mar 19, 2026 |
| 4 | Insider transaction | Mar 23, 2026 | Mar 19, 2026 |
| 4 | Insider transaction | Mar 23, 2026 | Mar 19, 2026 |
| 4 | Insider transaction | Mar 23, 2026 | Mar 19, 2026 |
| 4 | Insider transaction | Mar 23, 2026 | Mar 19, 2026 |
| 4 | Insider transaction | Mar 23, 2026 | Mar 19, 2026 |
| 4 | Insider transaction | Mar 23, 2026 | Mar 19, 2026 |
| 4 | Insider transaction | Mar 23, 2026 | Mar 19, 2026 |
| 4 | Insider transaction | Mar 23, 2026 | Mar 19, 2026 |
| 4 | Insider transaction | Mar 23, 2026 | Mar 19, 2026 |
| 4 | Insider transaction | Mar 23, 2026 | Mar 19, 2026 |
| 4 | Insider transaction | Mar 23, 2026 | Mar 19, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 20, 2026 | Mar 19, 2026 |
| S-8 | Employee stock plan registration | Mar 17, 2026 | — |
| 10-K | Annual report | Mar 17, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2026 | Mar 17, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 16, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 13, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 13, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Mar 10, 2026 | Mar 8, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 20, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| 3 | Initial insider ownership | Feb 3, 2026 | Jan 26, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 29, 2026 | Jan 26, 2026 |
| 4 | Insider transaction | Jan 14, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Jan 14, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Jan 14, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 14, 2025 | — |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 4 | Insider transaction | Nov 6, 2025 | Nov 4, 2025 |
| 4 | Insider transaction | Nov 6, 2025 | Nov 4, 2025 |
| 4 | Insider transaction | Oct 14, 2025 | Oct 10, 2025 |
| 4 | Insider transaction | Oct 14, 2025 | Oct 10, 2025 |
| 4 | Insider transaction | Oct 14, 2025 | Oct 10, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K | Current report | Aug 12, 2025 | Aug 12, 2025 |
| 4 | Insider transaction | Jul 11, 2025 | Jul 10, 2025 |
| 4 | Insider transaction | Jul 11, 2025 | Jul 10, 2025 |
| 4 | Insider transaction | Jul 11, 2025 | Jul 10, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Jun 20, 2025 | Jun 17, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 18, 2025 | — |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 11, 2025 | Jun 11, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 4, 2025 | — |
| 4 | Insider transaction | Jun 3, 2025 | Jun 2, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 30, 2025 | — |
| 4 | Insider transaction | May 30, 2025 | May 28, 2025 |
| 4 | Insider transaction | May 29, 2025 | May 28, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 27, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 22, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K | Current report | May 13, 2025 | May 13, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | May 7, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 1, 2025 | May 1, 2025 |
| 4 | Insider transaction | Apr 11, 2025 | Apr 10, 2025 |
| 4 | Insider transaction | Apr 11, 2025 | Apr 10, 2025 |
| 4 | Insider transaction | Apr 11, 2025 | Apr 10, 2025 |
| 4 | Insider transaction | Apr 11, 2025 | Apr 10, 2025 |
| ARS | Annual report to shareholders | Apr 11, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 10, 2025 | — |
| DEF 14A | Proxy statement | Apr 10, 2025 | Apr 10, 2025 |
| S-8 | Employee stock plan registration | Mar 25, 2025 | — |
| 10-K | Annual report | Mar 25, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2025 | Mar 25, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 28, 2025 | — |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2025 | — |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Dec 23, 2024 | Dec 19, 2024 |
| 4 | Insider transaction | Dec 23, 2024 | Dec 19, 2024 |
| 4 | Insider transaction | Dec 23, 2024 | Dec 19, 2024 |
| 4 | Insider transaction | Dec 23, 2024 | Dec 19, 2024 |
| 4 | Insider transaction | Dec 23, 2024 | Dec 19, 2024 |
| 4 | Insider transaction | Dec 10, 2024 | Dec 6, 2024 |
| 4 | Insider transaction | Nov 27, 2024 | Nov 26, 2024 |
| 4 | Insider transaction | Nov 27, 2024 | Nov 27, 2024 |
| 4 | Insider transaction | Nov 21, 2024 | Nov 19, 2024 |
| 4 | Insider transaction | Nov 20, 2024 | Nov 18, 2024 |
| 4 | Insider transaction | Nov 18, 2024 | Nov 18, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 13, 2024 | — |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 4 | Insider transaction | Nov 5, 2024 | Nov 4, 2024 |
| 4 | Insider transaction | Nov 5, 2024 | Nov 4, 2024 |
| 3 | Initial insider ownership | Nov 5, 2024 | Nov 4, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 5, 2024 | Nov 4, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Aug 28, 2024 | — |
| 8-A12B | Filing | Aug 19, 2024 | — |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change
|
Aug 19, 2024 | Aug 15, 2024 |
| 144 | Notice of proposed sale | Aug 15, 2024 | — |
| 144 | Notice of proposed sale | Aug 15, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Aug 14, 2024 | — |
| 4 | Insider transaction | Aug 14, 2024 | Aug 14, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Aug 13, 2024 | — |
| 4 | Insider transaction | Aug 13, 2024 | Aug 9, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 3 | Initial insider ownership | Aug 12, 2024 | Aug 9, 2024 |
| SC 13G | Ownership over 5% (passive) | Aug 12, 2024 | — |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Regulation FD disclosure, Other events
|
Aug 8, 2024 | Aug 7, 2024 |
| 4 | Insider transaction | Jul 12, 2024 | Jul 10, 2024 |
| SC 13G | Ownership over 5% (passive) | Jul 3, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2024 | Jun 19, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 19, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 19, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 19, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 19, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 19, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 19, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 19, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 19, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| 10-K/A | Amended annual report | May 14, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 19, 2024 |
| SC 13G | Ownership over 5% (passive) | Apr 10, 2024 | — |
| PRE 14A | Preliminary proxy statement | Apr 5, 2024 | Jun 19, 2024 |
| S-8 | Employee stock plan registration | Mar 29, 2024 | — |
| 10-K | Annual report | Mar 29, 2024 | Dec 31, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ANTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Menlo Park, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1880438
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.